Environmental and genetic factors influencing inhibitor development.
D000483:Alleles; D000906:Antibodies / Q000097:blood; D019774:Blood Coagulation Factor Inhibitors / Q000235:genetics / Q000276:immunology*; D004781:Environmental Exposure / Q000009:adverse effects; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D005164:Factor IX / Q000235:genetics / Q000276:immunology; D005169:Factor VIII / Q000009:adverse effects / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D005805:Genes, MHC Class I / Q000276:immunology; D005802:Genes, MHC Class II / Q000276:immunology; D006467:Hemophilia A / Q000097:blood / Q000209:etiology / Q000235:genetics* / Q000276:immunology*; D002836:Hemophilia B / Q000097:blood / Q000209:etiology / Q000235:genetics* / Q000276:immunology*; D006801:Humans; D009154:Mutation / Q000276:immunology
D000906:Antibodies; D019774:Blood Coagulation Factor Inhibitors; D000939:Epitopes; C427184:recombinant factor VIII SQ; C078147:F8 protein, human; D005169:Factor VIII; D005164:Factor IX